Collins Kevin Walter's Form 4 filing
Lucira Health, Inc. (LHDX) · filed Mar 13, 2023
- Accession no.
- 0001209191-23-018223
- Filed
- Mar 13, 2023, 5:09 PM ET
- Trade date
- Mar 3-7, 2023
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $73.8K. It was filed 10 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Collins Kevin WalterCIK 0001870312 | Officer (Chief Revenue Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | Common Stock | SSaleDisposed | −30,102 | $1.15 | −$34,617.3 | 316,620 | Direct | |
| Mar 7, 2023 | Common Stock | SSaleDisposed | −81,717 | $0.48 | −$39,224.16 | 234,903 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.